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Abstract
Objective: to evaluate the performance of the 4 ‘A’s Test (4AT) in screening for delirium in older patients. The 4AT is a new
test for rapid screening of delirium in routine clinical practice.
Design: prospective study of consecutively admitted elderly patients with independent 4AT and reference standard assessments.
Setting: an acute geriatrics ward and a department of rehabilitation.
Participants: two hundred and thirty-six patients (aged ≥70 years) consecutively admitted over a period of 4 months.
Measurements: in each centre, the 4AT was administered by a geriatrician to eligible patients within 24 h of admission.
Reference standard delirium diagnosis (DSM-IV-TR criteria) was obtained within 30 min by a different geriatrician who was blind
to the 4AT score. The presence of dementia was assessed using the Alzheimer’s Questionnaire and the informant section of the
Clinical Dementia Rating scale. The main outcome measure was the accuracy of the 4AT in diagnosing delirium.
Results: patients were 83.9 ± 6.1 years old, and the majority were women (64%). Delirium was detected in 12.3% (n= 29),
dementia in 31.2% (n= 74) and a combination of both in 7.2% (n= 17). The 4AT had a sensitivity of 89.7% and speciﬁcity
84.1% for delirium. The areas under the receiver operating characteristic curves for delirium diagnosis were 0.93 in the whole
population, 0.92 in patients without dementia and 0.89 in patients with dementia.
Conclusions: the 4AT is a sensitive and speciﬁc method of screening for delirium in hospitalised older people. Its brevity and
simplicity support its use in routine clinical practice.
Keywords: delirium, cognitive impairment, screening, geriatrics, dementia, older people, validation, delirium detection, diagnostic
accuracy
Introduction
Delirium is a serious neuropsychiatric syndrome charac-
terised by acute and ﬂuctuating inattention, other cognitive
deﬁcits and alterations in level of consciousness [1]. It affects
11–30% of hospitalised older patients [2]. Delirium is inde-
pendently associated with several adverse outcomes, includ-
ing elevated costs, increased length of stay, long-term
cognitive and functional decline, increased risk of institution-
alisation, higher mortality, and patient and carer distress [3–
7]. Recognition of delirium can improve outcomes [8]. For
these reasons, detection is important. Yet 50–75% of delir-
ium is undetected or misdiagnosed in acute hospitals [6–9].
The 4 ‘A’s Test (4AT; www.the4AT.com) is a new screen-
ing tool for delirium. It also incorporates two simple cogni-
tive screening items. It was developed because, though many
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reliable and valid delirium screening tools exist, none
appeared to have all the following features important in
routine, non-specialist care: brevity (generally <2 min), no
special training required, simple to administer (including in
people with visual or hearing impairment), does not require
physical responses, allows for assessment of ‘untestable’
patients (those who cannot undergo cognitive testing or
interview because of severe drowsiness or agitation) and
incorporates general cognitive screening to avoid the need
for separate tools for delirium and other causes of cognitive
impairment. The 4AT underwent several waves of piloting,
and is already in use in multiple hospitals in the UK and
internationally. Here we aimed to test the diagnostic accuracy
of the 4AT against a reference standard in two populations of
older hospitalised patients.
Methods
This study adheres to the Standards for Reporting Diagnostic
Accuracy statement (www.stard-statement.org). It was a cross-
sectional observational study carried out at (i) the Geriatric
Medicine Unit at the University of Milano-Bicocca and
S. Gerardo Hospital, Monza and (ii) the Department of
Rehabilitation and Aged Care (DRAC), Ancelle della Carità
Hospital, Cremona, Italy, from 1 May to 31 August 2012. The
Geriatric Medicine Unit is a 38-bedded acute geriatric medi-
cine ward (total no. of patients/year 2012 = 1209) in a univer-
sity hospital, admitting patients mostly from the Emergency
Department. It also incorporates a six-bedded Orthogeriatrics
Unit (OGU) for elderly patients with hip fracture [10]. The
DRAC is an 80-bedded ward for inpatient rehabilitation of
post-acute and chronic disability in older patients [4]. The
most frequent reasons for admission are post-surgical
care, stroke, chronic heart failure and pulmonary diseases,
Parkinson’s disease, or gait/balance disorders.
All consecutively admitted patients aged 70 years or
above were eligible for inclusion. Exclusion criteria were
patients with no verbal communication, or comatose
[according to a score of −4 or less at the Richmond
Agitation and Sedation Scale (RASS)] [11], learning disability,
severe hearing disability, unable to speak Italian and lack of
interpreter or no informed consent. The institutional review
board of the Ethics Committee of the University of
Milano-Bicocca approved the study. Informed consent from
patients or their legal proxies was obtained.
The 4AT
The 4AT comprises four items. Item 1 assesses level of alert-
ness [12]. The next two items are brief cognitive screening
tests: the Abbreviated Mental Test—4 (AMT4) [13], and
attention testing with Months Backwards [14]. Item 4
assesses acute change or ﬂuctuation in mental status [1]. The
4AT is scored from 0 to 12. A score of 0 is intended to
suggest that delirium and/or moderate to severe cognitive
impairment is unlikely, though the latter possibility is not
being evaluated in the present study. Scores between 1 and 3
are intended to suggest possible moderate to severe general
cognitive impairment (that is, corresponding to moderate to
severe impairment on standalone dementia screening tools).
A score of 4 or above suggests possible delirium. The cut-off
of 3/4 was not derived; instead it was pre-speciﬁed in the
design of the instrument. A score of 4 or more can be gener-
ated by the positive level of alertness or change items, or
untestability on both cognitive items. Combinations of posi-
tive features may generate higher scores (for example, a
drowsy, untestable patient who has a clear change in mental
status would have a score of 12). Scores under 4 but above 0
suggest cognitive impairment. The 4AT (version 1) as used
in this study is provided in Supplementary data available in
Age and Ageing online, the Appendix, and is also available at
www.the4AT.com, along with the most recent version of the
guidance notes. The Italian version of the 4AT was a direct
translation from the English; this was readily achievable
because of the unambiguousness of the items.
Multi-dimensional assessment
On admission, one senior geriatrician at each centre (P.M. in
Monza, R.T. in Cremona) assessed each eligible patient with
the 4AT. No speciﬁc training in the use of the 4ATwas given.
Within 48 h of admission, the same assessor administered
the Alzheimer’s Questionnaire (AQ), a 21-item, informant-
based dementia assessment [15] to the patient’s families or
caregivers. The score ranges from 0 to 27, with a cut-off of 4
indicating likely cognitive impairment. The informant section
of the Clinical Dementia Rating (CDR) [16] scale was admi-
nistered to patients who scored >5 on the AQ. In addition, a
standardised multidimensional geriatric assessment was
carried out by the same assessors. Comorbidity was quanti-
ﬁed with the Charlson index [17]. The presence of likely
dementia was derived using AQ and CDR scores.
Reference standard diagnosis of delirium
The diagnosis of delirium was made according to DSM-IV-
TR criteria [1] in each centre by an expert assessor (G.B. in
Monza and A.M. in Cremona). The reference standard as-
sessment was undertaken 15–30 min after the 4AT assess-
ment, without knowledge of the 4AT score. The reference
standard diagnostic procedure included the short Confusion
Assessment Method (CAM) [18] with additional assessments
as detailed below. The patient interaction started with the
introduction of the assessor’s name and role, followed by
asking the patient’s name and address, and orientation to
time, place and person. Fluctuation of symptoms was ascer-
tained through informant history from nursing staff and the
patient’s carers. Questions used included ‘Has there been a
sudden change in patient’s mental state since coming into
hospital?’; ‘Does the patient seem better at any period in the
day compared to other times?’; ‘Has his/her level of con-
sciousness been altered at all - for example, has he/she been
drowsy or not interacting, or perhaps agitated at times?’.
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Attention was evaluated using several methods. First, the
patient was asked to state the days of the week forward and
backwards, and to count backwards from 20 to 1. Any error
in each of these tasks was considered as inattention. An add-
itional test was the SAVEAHAART vigilance task embedded
in the Confusion Assessment Method- ICU (CAM-ICU)
[19], where the assessor recites the sequence of letters slowly
and the patient is asked to indicate when the letter ‘A’ is
recited. Inattention was deﬁned as the presence of more than
two errors, as per CAM-ICU manual. During each of these
tasks, the examiner observed the patient’s distractibility, com-
prehension and the tendency to lose the thread of conversa-
tion. Level of consciousness was assessed using the RASS
[11]. The assessment of disorganised thinking was per-
formed by asking the patient a list of pre-deﬁned questions,
such as ‘Why are you in hospital?’; ‘Will a stone ﬂoat on
water?’; ‘Are there ﬁsh in the sea?’. Any error in each of these
tasks was considered to indicate disorganised thinking.
Additionally, assessors recorded sleep-wake cycle distur-
bances, psychomotor abnormalities (including abnormal
motor behaviour), perceptual disturbances, short- and long-
term memory disturbances, psychotic symptoms and
depressed mood, as derived from the clinical notes and
patient interview. These assessments were used in combin-
ation against the DSM-IV-TR criteria, with the objective indi-
cators described above supplemented by the assessors’
judgement regarding the subjective features.
Outcome measures
The primary outcome measure was the accuracy of 4AT scores
in diagnosing delirium. Secondary measures included assessing
4AT accuracy in patients with and without dementia, and the
performance of each item in relation to delirium diagnosis.
Statistical analyses
All analyses were conducted with Stata 12.1 (StataCorp,
USA). Differences in characteristics of persons with and
without delirium were assessed using the t-test or rank-sum
test for continuous variables, and the χ2 test for proportions.
Cronbach’s α was calculated for the internal reliability of the
4AT. Diagnostic test accuracy was assessed using receiver op-
erating characteristic (ROC) curves to yield sensitivity, speciﬁ-
city, positive and negative likelihood ratios and area under the
ROC curve (AUROC), along with 95% conﬁdence intervals.
Results
We studied 248 patients, 142 in Monza and 106 in Cremona.
Informed consent could not be obtained for ﬁve patients.
Twelve patients were excluded because the time interval between
the 4AT and the reference standard assessments exceeded 30
min. The ﬁnal number of patients in the study sample was 234.
Table 1 shows the clinical and demographic features. The
mean age was 83.9 ± 6.1; 150 (64%) patients were women.
Twenty-nine patients (12%) had delirium according to
the reference standard. Dementia prevalence according to
the AQ and CDR assessment was 31.2% (n = 74). The
prevalence of delirium superimposed on dementia was 23%
(n = 17). Participants with delirium were signiﬁcantly more
likely to have dementia. More patients had delirium in the
OGU (25/130) than in the DRAC (7/106).
The cut-off of 3/4 for delirium assessment, as per the
4AT speciﬁcations, was used a priori. In the whole sample,
sensitivity was 89.7%, and speciﬁcity was 84.1%. The ROC
curves are shown in Figure 1. The areas under the curves
were: 0.93 in the whole population, 0.92 in patients without
dementia and 0.89 in those with dementia. Other sensitiv-
ities, speciﬁcities and positive and negative likelihood ratios
are given in Figure 1, showing good speciﬁcity to delirium in
a dementia-free population, and good sensitivity to delirium
in a dementia population. Cronbach’s α for internal consist-
ency was good, at 0.80.
Table 2 shows the diagnostic performance of each com-
ponent of the 4AT. In the whole sample, the alertness and
acute change/ﬂuctuation items were highly speciﬁc (96.1 and
94.2%, respectively). The AMT4 and Months Backwards
tests were sensitive to delirium (96.6 and 93.1% with a score
of 1 and 89.7 and 86.2% for a score of 2, respectively); the
speciﬁcity of alertness and acute change/ﬂuctuation was ex-
cellent in persons without dementia (99.3 and 98.0%, re-
spectively) while it was good or very good in those with
dementia (87.7 and 83.9%, respectively). The sensitivity of
AMT4 and Months Backwards were both high for a score of
1 (91.7 and 83.3%) and lower for a score of 2 (75.0% for
both components) in persons without dementia. In those
with dementia, it was highest for a score of 1 (100% for both
components) and highest or very high for a score of 2 (100
and 94.1%, respectively).
Discussion
We found that the 4AT is a valid method of screening delir-
ium in elderly patients on admission to geriatric wards, with
overall high sensitivity and speciﬁcity. Speciﬁcity was higher
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Clinical characteristics of the study population, by
delirium status
No delirium Delirium P-value
n 207 29
Age (mean, SD) 83.6 5.9 85.5 7.3 0.12
Sex (F, %) 131 63% 19 66% 0.85
Dementia (n, %) 57 28% 17 59% <0.01
Clinical dementia rating score
0 127 61% 10 34% 0.003
0.5 23 11% 2 7%
1 30 14% 6 21%
2 18 9% 5 17%
3 9 4% 6 21%
Charlson index (median, IQR) 2 (1–4) 2 (1–3) 0.42
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in the subgroup of patients without dementia, while sensitiv-
ity was higher in those with dementia. We also found that
the level of alertness and ﬂuctuation items drove speciﬁcity
to delirium, while the AMT4 (orientation) and Months
Backwards (attention) items drove sensitivity to delirium.
Despite its importance, delirium continues to be misdiag-
nosed, detected late or missed in well over 60% of cases
[9, 20].While there are several reasons for this, one contribu-
tor is likely to be the lack of screening tools which are brief
and do not rely on formal training. A recent systematic
review identiﬁed 11 published screening tools [21]. However,
the sensitivity of most of these tools is not satisfactory
without formal training [9] and providing such training is dif-
ﬁcult in clinical practice [22].
Acute onset and ﬂuctuation are core diagnostic features of
delirium and as expected the 4AT item assessing this feature
was highly speciﬁc. Notably, the alertness item was also highly
speciﬁc. A drawback of some delirium screening tools is that
the scoring mechanism does not readily allow categorisation
of patients whose level of arousal is too abnormal to have at-
tention assessed by interview or cognitive testing. Yet clinical
experience and the available studies [12] suggest that such
patients (when not comatose) are highly likely to have a diag-
nosis of delirium. Therefore, in a brief screening tool, the
safest approach and indeed the approach most closely aligned
to the evidence is to consider such patients as having delirium
unless otherwise proven otherwise [12, 23]. The 4AT provides
two ways in which these patients can be described as ‘possible
delirium’. First, clear abnormality of level of alertness is scored
at 4. Second, if patients are considered ‘untestable’ on the
AMT4 and Months Backwards tests, this also gives a score of
4. A caveat regarding this scoring mechanism is that severe
chronic cognitive impairment might also yield a score of
4. However, the 4AT is a screening tool, and so ‘untestable’
patients in any case require further assessment before a deﬁni-
tive diagnosis can be made.
The AMT4 and Months Backwards items showed good
sensitivity, but lower speciﬁcity for delirium. These ﬁndings
Figure 1. ROC comparison curve for the 4AT versus the diagnosis of delirium (DSM IV-TR criteria) in the whole population and in
subgroups of patients with and without dementia.
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conﬁrm the value of cognitive tests in detecting delirium, but
also show that cognitive screening alone, with these tests at
least, is insufﬁciently speciﬁc. Nevertheless, the speciﬁcity was
higher with more severe deﬁcits, such as 2 or more errors on
the AMT4, or untestability in both tests. These ﬁndings
suggest that both severe disorientation and inability to
perform simple cognitive tests are useful markers of delirium.
Though inattention is a core diagnostic feature of delir-
ium, there is no consensus on how it should be assessed [23],
with multiple subjective and objective methods in use clinic-
ally and in published scales. This is important because these
methods vary considerably in sensitivity, reliability and other
parameters, with signiﬁcant implications for diagnostic
thresholds. There are particular challenges where dementia is
also present [24], because attentional deﬁcits are also fre-
quently present in dementia. The Months Backwards test
was included in the 4AT as an established measure of inatten-
tion in delirium [25]. It was also included as an indicator of
general cognitive impairment, because deﬁcits in this test are
also evident in dementia [14]. The present results conﬁrm
that Months Backwards is not speciﬁc to delirium, and
indeed performs similarly to the AMT4 with respect to sensi-
tivity and speciﬁcity in relation to delirium. Further work will
establish if Months Backwards or other simple bedside ob-
jective tests of attention can provide sensitive and speciﬁc
measures of inattention in delirium; some research suggests
that this is potentially feasible [26].
A strength of this study is the provision of a clear descrip-
tion of exactly how the delirium diagnosis was obtained, detail-
ing the procedure which informed scoring by DSM-IV-TR
criteria. Another strength is that the study was performed
outside the centre in which the 4ATwas developed. Some lim-
itations of this study must be acknowledged. The 4AT assess-
ments were performed by experienced physicians, though no
speciﬁc training in the 4AT was given. Further research is
needed to assess the ease of use of 4AT among other profes-
sional groups of varying levels of seniority. We did not study
the clinical outcomes in relation to ‘possible delirium’ as
assessed by the 4AT. We did not assess the diagnostic accuracy
of the AMT4 and Months Backwards items in relation to
general cognitive impairment, though this was not the focus
of this study. The prevalence of delirium in this study was
comparable with that reported in previous studies (10–31% in
medical inpatients and 13% in post-acute care rehabilitation [2,
4]), albeit at the lower end of the spectrum for acute inpatients.
Future studies should expand the range of settings studied, in-
cluding in samples with higher rates of delirium. We did not
assess inter-rater reliability for the 4AT or the reference stand-
ard assessment; this should be addressed in future studies.
Also, because of insufﬁcient power, we were not able to
analyse the characteristics of misclassiﬁed (false negative and
false positive) patients. Finally, we did not assess the subtypes
of delirium, the discriminant validity of 4AT in identifying de-
lirium from depression, and how the scores relate to severity
of delirium.
In conclusion, this study suggests that the 4AT is a valid
screening tool for delirium detection in geriatrics wards.
Given its brevity and practicality, it appears a useful addition
to the available tests for delirium screening, in particular for
use in routine clinical practice. It incorporates two items for
initial testing for moderate to severe cognitive impairment
which means that a separate instrument for this purpose may
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. Diagnostic test accuracy of each component of the 4AT in relation to reference standard delirium diagnosis in the
whole sample and in persons with and without dementia
Score Sensitivity (%) Specificity (%) LR+ LR− AUROC
Whole sample
Alertness 4 53.2 96.1 14.276 0.466 0.757
AMT4 1 96.6 54.6 2.126 0.063 0.864
2 89.7 80.2 4.527 0.129
Attention 1 93.1 49.8 1.853 0.139 0.850
2 86.2 82.6 4.957 0.167
Acute change/fluctuation 4 69.0 94.2 11.839 0.330 0.816
Dementia
Alertness 4 50.0 99.3 75.000 0.503 0.747
AMT4 1 91.7 64.7 2.594 0.129 0.865
2 75.0 89.3 7.031 0.280
Attention 1 83.3 58.0 1.984 0.287 0.820
2 75.0 89.3 7.031 0.280
Acute change/fluctuation 1 58.3 98.0 29.167 0.425 0.782
No dementia
Alertness 4 58.8 87.7 4.790 0.469 0.733
AMT4 1 100.0 28.1 1.390 0.000 0.781
2 100.0 56.1 2.280 0.000
Attention 1 100.0 28.1 1.390 0.000 0.803
2 94.1 64.9 2.682 0.091
Acute change/fluctuation 1 76.5 83.9 4.758 0.280 0.802
LR+ and LR−, positive and negative Likelihood ratio, respectively. AUROC, area under the curve; n= 234 for whole sample; n= 76 in dementia subgroup; n= 160 in
160 no dementia subgroup.
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not be necessary. Further work is required to evaluate this
possibility. Future studies in larger populations and other
centres should further assess its performance, including the
determination of whether detection of delirium using the
4ATmay improve the clinical outcomes of patients.
Key points
• Although its recognition can improve patient outcomes, de-
lirium is often undetected in acute hospitals.
• The 4 ‘A’s Test is a screening tool for delirium that is brief
(generally <2 min), does not require special training, is
simple to administer, and allows for the assessment of
those who cannot undergo cognitive testing or interview
because of severe drowsiness or agitation.
• Our study evaluated the performance of the 4AT in screen-
ing for delirium in a population of older patients, consecu-
tively admitted over a period of 4 months to an acute
geriatrics ward and a rehabilitation department. The refer-
ence standard for delirium diagnosis was the DSM-IV cri-
teria, blind to the 4AT score.
• The results suggest that the 4AT is an effective method of
screening for delirium in hospitalised older people. Its
brevity and simplicity support its use in routine clinical
practice. Further studies are required to conﬁrm this.
Supplementary data
Supplementary data mentioned in the text is available to sub-
scribers in Age and Ageing online.
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